1,25-vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway

Journal of Molecular Endocrinology

Volumn 53, Issue 3, 2014, Pages 303-317

  Hlaing, Su M ^a   Garcia, Leah A ^a   Contreras, Jaime R ^a   Norris, Keith C ^b   Ferrini, Monica G ^a,b   Artaza, Jorge N ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

APC; Csnk1 1; Gsk3 ; VDR; Wnt11; catenin

Indexed keywords

CALCITRIOL; CASEIN KINASE IALPHA; CALCITRIOL RECEPTOR; COLECALCIFEROL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; MOLECULAR MECHANICS; MYOBLAST; MYOTUBE; NONHUMAN; PHENOTYPE; RAT; UPREGULATION; WNT SIGNALING PATHWAY; WNT11 GENE; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL NUCLEUS; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; CHOLECALCIFEROL; EMBRYO, MAMMALIAN; MYOCYTES, CARDIAC; PROTEIN TRANSPORT; RATS; RECEPTORS, CALCITRIOL; WNT SIGNALING PATHWAY;

EID: 84908367009     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0168     Document Type: Article

References (71)

1. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J et al. 2012 Activation of canonical Wnt signalling is required for TGF-b-mediated fibrosis. Nature Communications 3 735. doi:10.1038/ncomms1734
2. Artaza JN & Norris KC 2009 Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. Journal of Endocrinology 200 207–221. doi:10.1677/JOE-08-0241
3. Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, Meerasahib MF & Gonzalez-Cadavid NF 2005 Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146 3547–3557. doi:10.1210/en.2005-0362
4. Artaza JN, Reisz-Porszasz S, Dow JS, Kloner RA, Tsao J, Bhasin S & Gonzalez-Cadavid NF 2007 Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. Journal of Endocrinology 194 63–76. doi:10.1677/JOE-07-0072
5. Artaza JN, Singh R, Ferrini MG, Braga M, Tsao J & Gonzalez-Cadavid NF 2008 Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts. Journal of Endocrinology 196 235–249. doi:10.1677/JOE-07-0408
6. Artaza JN, Mehrotra R & Norris KC 2009 Vitamin D and the cardiovascular system. Clinical Journal of the American Society of Nephrology 4 1515–1522. doi:10.2215/CJN.02260409
7. 3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. Journal of Steroid Biochemistry and Molecular Biology 119 73–83. doi:10.1016/j.jsbmb.2010.01.001
8. Assalin HB, Rafacho BP, dos Santos PP, Ardisson LP, Roscani MG, Chiuso-Minicucci F, Barbisan LF, Fernandes AA, Azevedo PS, Minicucci MF et al. 2013 Impact of the length of vitamin D deficiency on cardiac remodeling. Circulation. Heart Failure 6 809–816. doi:10.1161/CIRCHEARTFAILURE.112.000298
9. 3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture. Virchows Archiv 444 175–182. doi:10.1007/s00428-003-0929-5
10. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K et al. 2003 Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 763–776. doi:10.1016/S0092-8674(03)00687-1
11. Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif JC, Brugada J, Nattel S & Mont L 2011 Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 123 13–22. doi:10.1161/CIRCULATIONAHA.110.938282
12. Bergmann MW.,2010 WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circulation Research 107 1198–1208. doi:10.1161/CIRCRESAHA.110.223768
13. Cadigan KM & Nusse R 1997 Wnt signaling: a common theme in animal development. Genes and Development 11 3286–3305. doi:10.1101/gad.11.24.3286
14. 3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney International 69 1377–1384. doi:10.1038/sj.ki.5000304
15. Cingolani OH 2007 Cardiac hypertrophy and the Wnt/Frizzled pathway. Hypertension 49 427–428. doi:10.1161/01.HYP.0000255947.79237.61
16. Dawson K, Aflaki M & Nattel S 2013 Role of the Wnt–Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. Journal of Physiology 591 1409–1432. doi:10.1113/jphysiol.2012.235382
17. Eelen G, Gysemans C, Verlinden L, Vanoirbeek E, De Clercq P, Van Haver D, Mathieu C, Bouillon R & Verstuyf A 2007 Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Current Medicinal Chemistry 14 1893–1910. doi:10.2174/092986707781058823
18. Eisenberg LM & Eisenberg CA 2006 Wnt signal transduction and the formation of the myocardium. Developmental Biology 293 305–315. doi:10.1016/j.ydbio.2006.02.014
19. Eisenberg LM & Eisenberg CA 2007 Evaluating the role of Wnt signal transduction in promoting the development of the heart. Scientific World Journal 7 161–176. doi:10.1100/tsw.2007.71
20. Endl E, Steinbach P, Knuchel R & Hofstadter F 1997 Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 29 233–241. doi:10.1002/(SICI)1097-0320(19971101)29:3!233::AID-CYTO6O3.0.CO;2-C
21. Essers J, Theil AF, Baldeyron C, van Cappellen WA, Houtsmuller AB, Kanaar R & Vermeulen W 2005 Nuclear dynamics of PCNA in DNA replication and repair. Molecular and Cellular Biology 25 9350–9359. doi:10.1128/MCB.25.21.9350-9359.2005
22. Flaherty MP & Dawn B., 2008 Noncanonical Wnt11 signaling and cardiomyogenic differentiation. Trends in Cardiovascular Medicine 18 260–268. doi:10.1016/j.tcm.2008.12.001
23. Flaherty MP, Abdel-Latif A, Li Q, Hunt G, Ranjan S, Ou Q, Tang XL, Johnson RK, Bolli R & Dawn B 2008 Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation 117 2241–2252. doi:10.1161/CIRCULATIONAHA.107.741066
24. Flaherty MP, Kamerzell TJ & Dawn B 2012 Wnt signaling and cardiac differentiation. Progress in Molecular Biology and Translational Science 111 153–174. doi:10.1016/B978-0-12-398459-3.00007-1
25. 12 skeletal muscle cells. Endocrinology 152 2976–2986. doi:10.1210/en.2011-0159
26. 12 skeletal muscle cells. Journal of Steroid Biochemistry and Molecular Biology 133 1–11. doi:10.1016/j.jsbmb.2012.09.004
27. Gerdes J, Schwab U, Lemke H & Stein H 1983 Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. International Journal of Cancer 31 13–20. doi:10.1002/ijc.2910310104
28. Giovannucci E, Liu Y, Hollis BW & Rimm EB 2008 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine 168 1174–1180. doi:10.1001/archinte.168.11.1174
29. Gotsman I, Shauer A, Zwas DR, Hellman Y, Keren A, Lotan C & Admon D 2012 Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. European Journal of Heart Failure 14 357–366. doi:10.1093/eurjhf/hfr175
30. He W, Dai C, Li Y, Zeng G, Monga SP & Liu Y 2009 Wnt/b-catenin signaling promotes renal interstitial fibrosis. Journal of the American Society of Nephrology 20 765–776. doi:10.1681/ASN.2008060566
31. Henderson WR, Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA & Kahn M 2010 Inhibition of Wnt/b-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. PNAS 107 14309–14314. doi:10.1073/pnas.1001520107
32. van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW & Roest M 2013 Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS ONE 8 e62080. doi:10.1371/journal.pone.0062080
33. Horan PK & Slezak SE 1989 Stable cell membrane labeling. Nature 340 167–168. doi:10.1038/340167a0
34. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, Robbins J & Lee RT 2007 Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nature Medicine 13 970–974. doi:10.1038/nm1618
35. 3 in vivo and in vitro. Molecular Endocrinology 18 2660–2671. doi:10.1210/me.2004-0116
36. Judd SE, Nanes MS, Ziegler TR, Wilson PW & Tangpricha V 2008 Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. American Journal of Clinical Nutrition 87 136–141.
37. Katoh M & Katoh M 2007 WNT signaling pathway and stem cell signaling network. Clinical Cancer Research 13 4042–4045. Review. doi:10.1158/1078-0432.CCR-06-2316
38. Kendrick J, Targher G, Smits G & Chonchol M 2009 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205 255–260. doi:10.1016/j.atherosclerosis.2008.10.033
39. 3 metabolites induce osteogenic differentiation in human dental pulp and human dental follicle cells. Journal of Steroid Biochemistry and Molecular Biology 122 133–141. doi:10.1016/j.jsbmb.2010.08.001
40. Kim DH, Sabour S, Sagar UN, Adams S & Whellan DJ 2008 Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). American Journal of Cardiology 102 1540–1544. doi:10.1016/j.amjcard.2008.06.067
41. Kimes BW & Brandt BL 1976 Properties of a clonal muscle cell line from rat heart. Experimental Cell Research 98 367–381. doi:10.1016/0014-4827(76)90447-X
42. Kwon C, Arnold J, Hsiao EC, Taketo MM, Conklin BR & Srivastava D 2007 Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. PNAS 104 10894–10899. doi:10.1073/pnas.0704044104
43. Lanier M, Schade D, Willems E, Tsuda M, Spiering S, Kalisiak J, Mercola M & Cashman JR 2012 Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure–activity relationship study based on inhibitors for the Wnt response. Journal of Medicinal Chemistry 55 697–708. doi:10.1021/jm2010223
44. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R & Norris K 2007 Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 167 1159–1165. doi:10.1001/archinte.167.11.1159
45. Martins D, Meng Y, Tareen N, Artaza J, Lee JE, Farodolu C, Gibbons G & Norris K 2014 The effect of short term vitamin D supplementation on the inflammatory and oxidative mediators of arterial stiffness. Health 6 1503–1511. doi:10.4236/health.2014.612185
46. Marvin MJ, Di Rocco G, Gardiner A, Bush SM & Lassar AB 2001 Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes and Development 15 316–327. doi:10.1101/gad.855501
47. Meems LM, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Sillje´ HH, Ruifrok WP & de Boer RA 2012 The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. Journal of Steroid Biochemistry and Molecular Biology 132 282–289. doi:10.1016/j.jsbmb.2012.06.004
48. Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J & Raggi P 2008 Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arteriosclerosis, Thrombosis, and Vascular Biology 28 1179–1185. doi:10.1161/ATVBAHA.108.165886
49. Nadal-Ginard B, Kajstura J, Leri A & Anversa P 2003 Myocyte death, growth and regeneration in cardiac hypertrophy and failure. Circulation Research 92 139–150. doi:10.1161/01.RES.0000053618.86362.DF
50. Naito T, Shiojima I, Akazawa H, Hidaka K, Morisaki T, Kikuchi A & Komuro I 2006 Developmental stage-specific biphasic roles of Wnt/b-catenin signaling in cardiomyogenesis and hematopoiesis. PNAS 103 19812–19817. doi:10.1073/pnas.0605768103
51. Naqvi N, Li M, Calvert JW, Tejada T, Lambert JP, Wu J, Kesteven SH, Holman SR, Matsuda T, Lovelock JD et al. 2014 A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 157 795–807. doi:10.1016/j.cell.2014.03.035
52. 3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. Journal of Steroid Biochemistry and Molecular Biology 103 533–537. doi:10.1016/j.jsbmb.2006.12.099
53. Norman AW 2006 Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147 5542–5548. doi:10.1210/en.2006-0946
54. Perán M, Marchal JA, López E, Jiménez-Navarro M, Boulaiz H, Rodríguez-Serrano F, Carrillo E, Sánchez-Espin G, de Teresa E, Tosh D et al. 2010 Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy 12 332–337. doi:10.3109/14653240903548202
55. 3. Endocrinology and Metabolism Clinics of North America 39 255–269. doi:10.1016/j.ecl.2010.02.007
56. Preusser M, Heinzl H, Gelpi E, Hoftberger R, Fischer I, Pipp I, Milenkovic I, Wohrer A, Popovici F & Wolfsberger S 2008 Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology 53 39–47. doi:10.1111/j.1365-2559.2008.03065.x
57. Rahman A, Hershey S, Ahmed S, Nibbelink K & Simpson RU 2007 Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. Journal of Steroid Biochemistry and Molecular Biology 103 416–419. doi:10.1016/j.jsbmb.2006.12.081
58. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zügel U & Roman J 2010 Vitamin D inhibition of pro-fibrotic effects of transforming growth factor b1 in lung fibroblasts and epithelial cells. Journal of Steroid Biochemistry and Molecular Biology 118 142–150. doi:10.1016/j.jsbmb.2009.11.004
59. Razani B, Woodman SE & Lisanti MP 2002 Caveolae: from cell biology to animal physiology. Pharmacological Reviews 54 431–467. doi:10.1124/pr.54.3.431
60. Rohini A, Agrawal N, Koyani CN & Singh R 2010 Molecular targets and regulators of cardiac hypertrophy. Pharmacological Research 61 269–280. doi:10.1016/j.phrs.2009.11.012
61. Rohr S 2012 Arrhythmogenic implications of fibroblast–myocyte interactions. Circulation. Arrhythmia and Electrophysiology 5 442–452. doi:10.1161/CIRCEP.110.957647
62. Scragg R, Sowers M & Bell C 2007 Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. American Journal of Hypertension 20 713–719. doi:10.1016/j.amjhyper.2007.01.017
63. Simpson RU, Hershey SH & Nibbelink KA 2007 Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. Journal of Steroid Biochemistry and Molecular Biology 103 521–524. doi:10.1016/j.jsbmb.2006.12.098
64. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterson AG et al. 2010 Small-molecule inhibition of Wnt signaling through activation of casein kinase 1a. Nature Chemical Biology 6 829–836. doi:10.1038/nchembio.453
65. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L & Simpson RU 2008 Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 149 558–564. doi:10.1210/en.2007-0805
66. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, Reinecke H, Moon RT & Murry CE 2007 Biphasic role for Wnt/b-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. PNAS 104 9685–9690. doi:10.1073/pnas.0702859104
67. 3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Molecular and Cellular Endocrinology 142 57–65. doi:10.1016/S0303-7207(98)00117-8
68. 3 in HL60 cells. Cancer Research 56 264–267.
69. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M & Vasan RS 2008 Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 503–511. doi:10.1161/CIRCULATIONAHA.107.706127
70. Willems E, Spiering S, Davidovics H, Lanier M, Xia Z, Dawson M, Cashman J & Mercola M 2011 Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circulation Research 109 360–364. doi:10.1161/CIRCRESAHA.111.249540
71. Zhang Z, Li H, Ma Z, Feng J, Gao P, Dong H & Zhang Z 2012 Efficient cardiomyogenic differentiation of bone marrow mesenchymal stromal cells by combination of Wnt11 and bone morphogenetic protein 2. Experimental Biology and Medicine 237 768–776. doi:10.1258/ebm.2012.011291